MedTrace Logo

Comparison of 7-Day ECG Patches

NCT07564349 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-05-04

No results posted yet for this study

Summary

This prospective, randomized, multi-arm study evaluates the usability and performance of commercially available CE-certified 7-day ECG patches in an outpatient setting. Participants aged ≥65 years requiring ECG monitoring as part of routine care will be randomized to one of six ECG patch devices. The study aims to assess the proportion of analyzable ECG recordings and overall recording quality over a 7-day period.

Conditions

Interventions

DEVICE

Smartcardia 7L Patch

CE-certified multi-parameter ECG patch including additional physiological monitoring

DEVICE

ECG247

CE-certified ECG patch with smartphone-based data transmission.

DEVICE

HeartX Recorder

CE-certified ECG patch designed for long-term continuous rhythm monitoring.

DEVICE

Kardiobeat

CE-certified multi-lead ECG patch for continuous cardiac monitoring

DEVICE

net_ECG

CE-certified 3 lead ECG patch designed for long-term continuous rhythm monitoring.

DEVICE

ZIO Patch

CE-certified single-lead ECG patch for long-term continuous rhythm monitoring

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Michael Schreinlechner, MD · Medical University Innsbruck

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-18
Primary Completion
2026-05-01
Completion
2026-05-01

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07564349 on ClinicalTrials.gov